Sign in
Active, not recruitingNo phase

Dietary Management of Gestational Diabetes

Key facts

Who runs it
Helsinki University Central Hospital
Where
Finland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
42 people enrolled
Started
3 Dec 2018
Expected to end
30 Dec 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Carbohydrate restricted diet
  • Plant-protein based diet
Record updated
24 September 2025

Who can take part

Sex
Women only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Gestational diabetes at enrollment

Who cannot take part

  • Cholesterol medication
  • Drug or alcohol abuse
  • Food allergies or restrictions (other than lactose intolerance)
  • Type 1 or type 2 diabetes
  • Psychiatric illness which affects participation in the study
  • Medication which affects glucose metabolism
  • Gestational weeks exceed 28+6
  • Multiple pregnancy
  • Mother's or father's ethnic background other than Caucasian
  • Factors hampering communication (e.g. lack of Finnish skills)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

eMOM is a randomized, controlled trial to compare the effects of two different dietary interventions during pregnancy. The comparison is based on tissue glucose content (using continuous glucose monitoring system) in pregnant women and on neonate body composition. The recruited women (n=60) have been diagnosed with gestational diabetes mellitus, and are of Caucasian origin. Of the study diets, one is moderately carbohydrate restricted and the other one is high on plant-based protein with an emphasis on healthy Nordic foods. The study has two two-week study periods that are carried out on approximately gestational weeks 24-28 (period I) and 34-36 (period II). Continuous glucose monitoring and other measurements (accelerometer, 3-day food record, gut microbiota, serum lipids, metabolomics, epigenetics etc.) are done during these study periods. At the beginning of the study, before study period I, the participants are randomized to either one of the intervention diets. The first study period consists of a crossover phase in which the participants receive three days' worth of food according to one of the intervention diets (according to the randomization) after which there is a three-day wash-out period. After the wash-out period, the participants receive three days' worth of food according to the other diet. After the first study period, a nutritionist advises the lastly followed intervention diet to the participant and the diet is followed until delivery. To ensure the diet is followed, the participants gets at least three personal face-to-face counseling sessions, phone calls, mobile reminders, recipes and food items. After delivery, the infant's body composition, epigenetic markers of cord blood and placenta, gut microbiome and urine metabolomics are measured.

The 2 groups in the trial

  • Carbohydrate restricted dietTreatment being tested

    Dietary intervention: moderately carbohydrate restricted diet. Parallel phase starts after study period I and the diet is followed until labor.

  • Plant-protein based dietTreatment being tested

    Dietary intervention: plant-protein based diet, en emphasis on healthy Nordic foods. Parallel phase starts after study period I and the diet is followed until labor.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Guided Dietary Patterns on Metabolic Outcomes in Overweight Pregnant Women With Gestational Diabetes and on Offspring Body Composition
Publications
Record updated
24 September 2025